Unternehmen Boston Therapeutics, Inc. Other OTC
Aktien
BTHE
US1011501004
BTHE
Medizinische Ausrüstung
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director of Finance/CFO | - | 19.01.23 | |
Bradley Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 01.11.22 |
Vidur Sahney
COO | Chief Operating Officer | - | 31.03.22 |
John Hardesky
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Jerry Fiddler
BRD | Director/Board Member | 72 | - |
Chairman | 69 | - | |
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director/Board Member | 67 | - | |
Tadd Lazarus
BRD | Director/Board Member | - | 31.08.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 540 | 0 | 0 | 42,05 % |
Aktie B | 0 | 377 | 0 | 0 | |
Aktie C | 1 | 48 996 763 | 20 604 326 ( 42,05 %) | 0 |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+33.63% | 8.68 Mrd. | |
+38.91% | 4.56 Mrd. | |
-29.91% | 2.72 Mrd. | |
-8.96% | 1.61 Mrd. | |
-21.61% | 1.34 Mrd. | |
-37.12% | 1.08 Mrd. | |
+2.06% | 929 Mio. | |
-42.75% | 791 Mio. | |
-23.56% | 675 Mio. |